Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting

Guillermo Rodriguez-Nava, Maria Adriana Yanez-Bello, Daniela Patricia Trelles-Garcia, Chul Won Chung, Harvey J Friedman, David W Hines, Guillermo Rodriguez-Nava, Maria Adriana Yanez-Bello, Daniela Patricia Trelles-Garcia, Chul Won Chung, Harvey J Friedman, David W Hines

Abstract

Objective: To evaluate the performance of the Quick COVID-19 Severity Index (qCSI) and the Brescia-COVID Respiratory Severity Scale (BCRSS) in predicting intensive care unit (ICU) admissions and in-hospital mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia.

Methods: This was a retrospective cohort study of 313 consecutive hospitalized adult patients (18 years or older) with confirmed COVID-19. The area under the receiver operating characteristic curve (AUC) was used to assess the discriminatory power of the qCSI score and BCRSS prediction rule compared to the CURB-65 score for predicting mortality and intensive care unit admission.

Results: The overall in-hospital fatality rate was 32.3%, and the ICU admission rate was 31.3%. The CURB-65 score had the highest numerical AUC to predict in-hospital mortality (AUC 0.781) compared to the qCSI score (AUC 0.711) and the BCRSS prediction rule (AUC 0.663). For ICU admission, the qCSI score had the highest numerical AUC (AUC 0.761) compared to the BCRSS prediction rule (AUC 0.735) and the CURB-65 score (AUC 0.629).

Conclusions: The CURB-65 and qCSI scoring systems showed a good performance for predicting in-hospital mortality. The qCSI score and the BCRSS prediction rule showed a good performance for predicting ICU admission.

Keywords: COVID-19; CURB-65; SARS-CoV-2; Scoring systems.

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
ROC curves for in-hospital mortality for the CURB-65, qCSI, and BCRSS scores. The solid line shows the ROC curve of the CURB-65 score. The dashed line shows the ROC curve of the qCSI score. The dotted line shows the ROC curve of the BCRSS score.
Figure 2
Figure 2
ROC curves for ICU admission for the CURB-65, qCSI, and BCRSS scores. The solid line shows the ROC curve of the CURB-65 score. The dashed line shows the ROC curve of the qCSI score. The dotted line shows the ROC curve of the BCRSS score.

References

    1. Bauchner H., Sharfstein J. A Bold Response to the COVID-19 Pandemic: Medical Students, National Service, and Public Health. JAMA. 2020;323(18):1790–1791. doi: 10.1001/jama.2020.6166.
    1. Bewick V., Cheek L., Ball J. Statistics review 13: receiver operating characteristic curves. Crit Care. 2004;8(6):508–512. doi: 10.1186/cc3000.
    1. Capelastegui A., España P.P., Quintana J.M. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J. 2006;27(1):151–157. doi: 10.1183/09031936.06.00062505.
    1. Cascella M., Rajnik M., Cuomo A., Dulebohn S.C., Di Napoli R. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2020. Features, Evaluation, and Treatment of Coronavirus. 2020 October 4. Jan–. PMID.
    1. Cavallo J.J., Donoho D.A., Forman H.P. Hospital Capacity and Operations in the Coronavirus Disease 2019 (COVID-19) Pandemic—Planning for the Nth Patient. JAMA J Am Med Assoc [Internet] 2020 (March 17 2020). (Accessed 25 September 2020)
    1. Centers for Disease Control and Prevention . 2020. Coronavirus Disease 2019 (COVID-19) - Cases in the US.
    1. Anon Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service. Q J Med. 1987;62(239):195–220. PMID: 3116595.
    1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–544. doi: 10.1038/s41564-020-0695-z.
    1. Duca A., Piva S., Focà E., Latronico N., Rizzi M. Calculated Decisions: Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm. Emerg Med Pract. 2020;22(5 Suppl):CD1–CD2. PMID: 32297727.
    1. Emanuel E.J., Persad G., Upshur R. Fair Allocation of Scarce Medical Resources in the Time of Covid-19. N Engl J Med. 2020;382(21):2049–2055. doi: 10.1056/NEJMsb2005114.
    1. Kirkpatrick J.N., Hull S.C., Fedson S., Mullen B., Goodlin S.J. Scarce-Resource Allocation and Patient Triage During the COVID-19 Pandemic: JACC Review Topic of the Week. J Am Coll Cardiol. 2020;76(1):85–92. doi: 10.1016/j.jacc.2020.05.006.
    1. Fan G., Tu C., Zhou F. Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study. Eur Respir J. 2020;56(3) doi: 10.1183/13993003.02113-2020.
    1. Fine M.J., Auble T.E., Yealy D.M. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250. doi: 10.1056/NEJM199701233360402.
    1. Guan W.J., Ni Z.Y., Hu Y. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032.
    1. Haimovich A.D., Ravindra N.G., Stoytchev S., Young H.P., Wilson F.P., van Dijk D. Development and validation of the quick covid-19 severity index: a prognostic tool for early clinical decompensation. Ann Emerg Med. 2020;76(4):442–453. doi: 10.1016/j.annemergmed.2020.07.022.
    1. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36. doi: 10.1148/radiology.143.1.7063747.
    1. Jeong B.H., Koh W.J., Yoo H. Performances of prognostic scoring systems in patients with healthcare-associated pneumonia. Clin Infect Dis. 2013;56(5):625–632. doi: 10.1093/cid/cis970.
    1. Lim W.S., van der Eerden M.M., Laing R. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382. doi: 10.1136/thorax.58.5.377.
    1. Liu Y.C., Kuo R.L., Shih S.R. COVID-19: The first documented coronavirus pandemic in history. Biomed J. 2020;43(4):328–333. doi: 10.1016/j.bj.2020.04.007.
    1. Neill A.M., Martin I.R., Weir R. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax. 1996;51(10):1010–1016. doi: 10.1136/thx.51.10.1010.
    1. Nguyen Y., Corre F., Honsel V. Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19. J Infect. 2020;81(3):e96–e98. doi: 10.1016/j.jinf.2020.05.049.
    1. Paranthaman K., Conlon C.P., Parker C., Mccarthy N. Resource allocation during an influenza pandemic. Emerging Infect Dis. 2008;14(3):520–522. doi: 10.3201/eid1403.071275.
    1. Satici C., Demirkol M.A., Sargin altunok E. Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19. Int J Infect Dis. 2020;98:84–89. doi: 10.1016/j.ijid.2020.06.038.
    1. Taubenberger J.K., Morens D.M. 1918 Influenza: the mother of all pandemics. Emerging Infect Dis. 2006;12(1):15–22. doi: 10.3201/eid1201.050979.
    1. Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782–793. doi: 10.1001/jama.2020.12839.
    1. Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
    1. Zhu N., Zhang D., Wang W. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する